Entero Healthcare Solutions Limited (BOM:544122)

Market Cap	74.93B +57.6%
Revenue (ttm)	71.28B +31.9%
Net Income	1.25B +22.3%
EPS	28.78 +22.4%
Shares Out	n/a
PE Ratio	59.75
Forward PE	38.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,873
Open	1,689.50
Previous Close	1,695.15
Day's Range	1,685.00 - 1,735.00
52-Week Range	944.00 - 1,919.25
Beta	n/a
Analysts	Strong Buy
Price Target	1,824.40 (+6.08%)
Earnings Date	Nov 14, 2026

About BOM:544122

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2018
• Employees: 4,671
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544122

Financial Performance

In fiscal year 2026, BOM:544122's revenue was 65.91 billion, an increase of 29.35% compared to the previous year's 50.96 billion. Earnings were 1.15 billion, an increase of 21.33%.

Analyst Summary

According to 5 analysts, the average rating for 544122 stock is "Strong Buy." The 12-month stock price target is ₹1,824, which is an increase of 6.08% from the latest price.

Price Target

₹1,824

(6.08% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error